Bank of America, Truist Financial, and Royal Bank of Canada lowered price targets for Alnylam Pharmaceuticals on July 14, 2026.
4 reports, 1 independent
Updated Sep 21
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America, Truist Financial, and Royal Bank of Canada lowered price targets for Alnylam Pharmaceuticals on July 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.
- Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
-
Bank of America
American multinational banking and financial services corporation
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Financial firms including Royal Bank of Canada, Morgan Stanley, Truist Financial, and Wells Fargo have announced target price increases and objective boosts.
- Financial firms including Royal Bank of Canada, Truist Financial, TD Cowen, and Barclays have announced price target increases for Medpace.
- Truist Financial dropped its price objective and set a buy rating, while Jefferies and Royal Bank of Canada also issued rating updates.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- Morgan Stanley, Jefferies Financial Group, and Royal Bank of Canada issued rating and price target updates on September 14, 2026.